By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

YposKesi 



Evry      France
Phone: n/a Fax: n/a


SEARCH JOBS

YposKesi (from the Greek Yposchesi, meaning 'promise') is the first French company to develop and produce gene and cell therapy products. Created in November 2016 by AFM-Téléthon and by the SPI fund managed by Bpifrance, this new company aims to make the first treatments available to patients and market them at a fair and controlled price, in accordance to the commitment made by its founders. Located in Evry (Essonne, France), this industrial platform is made up of more than 130 experts in bioproduction and has a first production building covering 5,000 m2 (formerly Généthon Bioprod). It is aiming at European leadership and, with this objective, by 2021 will bring together nearly 300 engineers, pharmacists, technicians and experts in three production buildings totaling 13,000 m2. It will thus meet the needs of AFM-Téléthon laboratories (Généthon and CECS/I-Stem), as well as those of academic and industrial biotechnology organizations, for clinical trials or post-MA (Marketing Authorization) distribution.

YEAR FOUNDED:

November 2016

LEADERSHIP:

CEO: Alain Lamproye


Key Statistics


Email:
Ownership: Private

Web Site: YposKesi
Employees:
Symbol: 
 



Industry
Pharmaceutical






Company News
//-->